Proteases display biased agonism at protease-activated receptors: Location matters

Molecular Interventions

Volumn 9, Issue 2, 2009, Pages 87-96

  Russo, Angela ^a,c   Soh, Unice J K ^b   Trejo, Joann ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b San Diego   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC; BETA ARRESTIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; CATHEPSIN G; G PROTEIN COUPLED RECEPTOR; GINGIPAIN R; GRANZYME A; INTERSTITIAL COLLAGENASE; KALLIKREIN; PLASMIN; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; TRYPSIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; HUMAN; NONHUMAN; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; REVIEW;

ANIMALS; HUMANS; MULTIGENE FAMILY; PEPTIDE HYDROLASES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN TRANSPORT; RECEPTORS, PROTEINASE-ACTIVATED; SIGNAL TRANSDUCTION;

EID: 65949091143     PISSN: 15340384     EISSN: 15432548     Source Type: Journal    
DOI: 10.1124/mi.9.2.8     Document Type: Review

References (73)

1. Coughlin, S.R. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Thromb. Haemost. 3, 1800-1814 (2005).
2. Arora, P., Ricks, T.K., and Trejo, J. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer J. Cell Sci. 120, 921-928 (2007).
3. Feistritzer, C. and Riewald, M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine-1-phosphate recep- tor-1 crossactivation. Blood 105, 3178-3184 (2005). The results in this article are one of the first to show that activation of PARI by APC versus thrombin can have opposite effects on endothelial barrier permeability. (Pubitemid 40504337)
4. Finigan, J.H., Dudek, S.M., Singleton, P.A., Chiang, E.T., Jacobson, J.R., Camp, S.M., Ye, S.Q., and Garcia, J.G.N. Activated protein C mediates novel lung endothelial barrier enhancement. J. Biol. Chem. 280, 17286-17293 (2005).
5. Russo, A., Soh, J.K., Paing, M.M., Arora, P., and Trejo, J. Caveolae are required for protease-selective signaling by protease-activated receptor-1. Proc. Natl Acad. Sci. USA [In press](2009). The results in this article show that caveolae are essential for APC, but not thrombin, activation of PAR1 demonstrating for the first time that caveolae mediate protease-selective signaling.
6. Urban, J.D., Clarke, W.P., von Zastrow, M. et al. Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp. Ther. 320, 1-13 (2007). An excellent comprehensive review on functional selectivity or biased agonism by GPCRs.
7. Zheng, H., Chu, J., Qiu, Y., Loh, H.H., and Law, P.-Y. Agonist-selective signaling is determined by the receptor location within the membrane domains. Proc. Natl. Acad. Sci. USA 105, 9421-9426 (2008). The results from this article show that MOR agonist-selective signaling and interaction with G-proteins and arrestins is regulated by localization in lipid rafts.
8. Vu, T.K., Hung, D.T., Wheaton, V.I., and Coughlin, S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068 (1991). (Pubitemid 121001193)
9. Ishihara, H., Connolly, A.J., Zeng, D., Kahn, M.L., Zheng, Y.W., Timmons, C., Tram, T., and Coughlin, S.R. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386, 502-506 (1997).
10. Kahn, M.L., Zheng, Y.W., Huang, W., Bigornia, V., Zeng, D., Moff, S., Farese, R.V., Jr., Tam, C., and Coughlin, S.R. A dual thrombin receptor system for platelet activation. Nature 394, 690-694 (1998).
11. Xu, W.F., Andersen, H., Whitmore, T.E., Presnell, S.R., Yee, D.P., Ching, A., Gilbert, T., Davie, E.W., and Foster, D.C. Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci. USA 95, 6642-6646 (1998).
12. Nystedt, S., Ramakrishnan, V., and Sundelin, J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J. Biol. Chem. 271, 14910-14915 (1996).
13. Kahn, M.L., Nakanishi-Matsui, M., Shapiro, M.J., Ishihara, H., and Coughlin, S.R. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest. 103, 879-887 (1999).
14. Sambrano, G.R., Weiss, E.J., Zheng, Y.W., Huang, W., and Coughlin, S.R. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 413, 74-78 (2001).
15. O'Brien, P.J., Prevost, N., Molino, M., Hollinger, M.K., Woolkalis, M.J., Woulfe, D.S., and Brass, L.F. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include transactiva- tion of PAR2 by thrombin-cleaved PAR1. J. Biol. Chem. 275, 13502-13509 (2000). (Pubitemid 30257415)
16. Kataoka, H., Hamilton, J.R., McKemy, D.D., Camerer, E., Zheng, Y.-W., Cheng, A., Griffin, C., and Coughlin, S.R. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 102, 3224-3231 (2003).
17. Ramachandran, R. and Hollenberg, M.D. Proteinases and signaling: Pathophysiological and therapeutic implications via PARs and more. Br. J. Phamacol. 153, S263-S282 (2008).
18. Traynelis, S.F. and Trejo, J. Protease-activated receptor signaling: New roles and regulatory mechanisms. Curr. Opin. Hematol. 14, 230-235 (2007).
19. Vu, T.K., Wheaton, V.I., Hung, D.T., and Coughlin, S.R. Domains specifying thrombin-receptor interaction. Nature 353, 674-677 (1991). (Pubitemid 21912589)
20. Nakanishi-Matsui, M., Zheng, Y.-W., Weiss, E.J., Sulciner, D., and Coughlin, S.R. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404, 609-613 (2000). (Pubitemid 30205059)
21. Seminario-Vidal, L., Kreda, S., Jones, L., O'Neal, W., Trejo, J., Boucher, R.C., and Lazarowski, E.R. Protease-activated receptor-3 promotes release of ATP from lung epithelial cells through coordinated activation of Rho- and Ca2+-dependent signaling pathways. J. Biol. Chem. In press(2009).
22. McLaughlin, J.N., Patterson, M.M., and Malik, A.B. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc. Natl. Acad. Sci. USA 104, 5662-5667 (2007).
23. Kaneider, N.C., Leger, A.J., Agarwal, A., Nguyen, N., Perides, G., Derian, C., Covic, L., and Kuliopulos, A. "Role reversal" for the receptor PAR1 in sepsis-induced vascular damage. Nat. Immunol. 12, 1303-1312 (2007).
24. Whorton, M.R., Bokoch, M.P., Rasmussen, S.G., Huang, B., Zare, R.N., Kobilka, B., and Sunahara, R.K. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl. Acad. Sci. USA 104, 7682-7687 (2007).
25. Baffy, G., Yang, L., Raj, S., Manning, D.R., and Williamson, J.R. G protein coupling to the thrombin receptor in Chinese hamster lung fibroblasts. J. Biol. Chem. 269, 8483-8487 (1994).
26. Offermanns, S., Toombs, C.F., Hu, Y.H., and Simon, M.I. Defective platelet activation in G alpha(q)-deficient mice. Nature 389, 183-186 (1997).
27. Benka, M.L., Lee, M., Wang, G.R. et al. The thrombin receptor in human platelets is coupled to a GTP binding protein of the G alpha q family. FEBS Lett. 363, 49-52 (1995).
28. Trejo, J., Connolly, A.J., and Coughlin, S.R. The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts. Loss of responses in fibroblasts from receptor knockout mice. J. Biol. Chem. 271, 21536-21541 (1996). (Pubitemid 26293021)
29. Lopez, I., Mak, E.C., Ding, J., Hamm, H.E., and Lomasney, J.W. A novel bifunctional phospholipase C that is regulated by G alpha 12 and stimulates the ras/mitogen-activated protein kinase pathway. J. Biol. Chem. 276, 2758-2765 (2001).
30. Offermanns, S., Laugwitz, K.-L., Spicher, K., and Schultz, G. G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc. Natl. Acad. Sci. USA 91, 504-508 (1994).
31. Gohla, A., Offermanns, S.G., Wilkie, T.M., and Schultz, G. Differential involvement of Ga12 and Ga13 in receptor-mediated Stress Fiber Formation. J. Biol. Chem. 274, 17901-17907 (1999).
32. DeFea, K.A., Zalevski, J., Thoma, M.S., Dery, O., Mullins, R.D., and Bunnett, N.W. p-Arrestin-dependent endocytosis of proteinase-activated receptor-2 is required for intracellular targeting of activated ERK1/2. J. Cell Biol. 148, 1267-1281 (2000).
33. Stalheim, L., Ding, Y., Gullapalli, A., Paing, M. M., Wolfe, B.L., Morris, D.R., and Trejo, J. Multiple independent functions of arrestins in regulation of protease-activated receptor-2 signaling and trafficking. Mol. Pharm. 67, 1-10 (2005).
34. Camerer, E., Huang, W., and Coughlin, S.R. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor Vila. Proc. Natl.Acad. Sci. USA 97, 5255-5260 (2000).
35. Riewald, M. and Ruf, W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc. Natl. Acad. Sci. USA 98, 7742-7747 (2001).
36. Riewald, M., Petrovan, R.J., Donner, A., Mueller, B.M., and Ruf, W. Activation of endothelial cell protease activated receptor-1 by the protein C pathway. Science 296, 1880-1882 (2002). (Pubitemid 34596276)
37. Stearns-Kurosawa, D.J., Kurosawa, S., Mollica, J.S., Ferrell, G.L., and Esmon, C.T. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc. Natl. Acad. Sci. USA 93, 10212-10216 (1996).
38. Mannaioni, G., Orr, A. G., Hamill, C. E. et al. Plasmin potentiates syn- aptic N-methly-D-aspartate receptor funtion in hippocampal neurons through activation of protease-activated receptor-1. J. Biol. Chem. 283, 20600-20611 (2008).
39. Kuliopulos, A., Covic, L., Seely, S.K., Sheridan, P.J., Helin, J., and Costello, C.E. Plasmin desensitization of the PAR1 thrombin receptor: Kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 38, 4572-4585 (1999). (Pubitemid 129514727)
40. Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., and Kuliopulos, A. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120, 303-313 (2005).
41. Ahamed, J., Versteeg, H.H., Kerver, M., Chen, V.M., Mueller, B.M., Hogg, P.J., and Ruf, W. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc. Natl. Acad. Sci. USA 45, 12020-12028 (2006).
42. Camerer, E. and Trejo, J. Cryptic messages: is noncoagulant tissue factor reserved for cell signaling? Proc. Natl. Acad. Sci. USA 103, 14259-14260 (2006). (Pubitemid 44484736)
43. Compton, S.J., Sandhu, S., Wijesuriya, S.J., and Hollenberg, M.D. Glycosylation of human protease-activated receptor-2 (hPAR2): Role in cell surface expression and signalling. Biochem. J. 368, 495-505 (2002). The results in this paper show for the first time that glycosylation differentially modulates trypsin versus tryptase activation of PAR2. (Pubitemid 35454527)
44. Al-Ani, B., Hansen, K.K., and Hollenberg, M.D. Proteinase-activated receptor-2: Key role of amino-terminal dipeptide residues of the tethered ligand for receptor activation. Mol. Pharm. 65, 149-156 (2004). The results shown in this article demonstrate that there are differences in the activation of PAR2 induced by proteolysis versus soluble synthetic peptide ligands. (Pubitemid 38113895)
45. Shapiro, M.J., Weiss, E.J., Faruqi, T.R., and Coughlin, S.R. Protease- activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J. Biol. Chem. 275, 25216-25221 (2000).
46. Holinstat, M., Voss, B., Bilodeau, M.L., McLaughlin, J.N., Cleator, J., and Hamm, H.E. PAR4, but not PAR1, signals in human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation. J. Biol. Chem. 281, 26665-26674 (2006). (Pubitemid 44401875)
47. Blackhart, B.D., Ruslim-Litrus, L., Lu, C.C., Alves, V.L., Teng, W., Scarborough, R.M., Reynolds, E.E., and Oksenberg, D. Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide. Mol. Pharm. 58, 1178-1187 (2000). The results in this article show for one of the first times that distinct cellular responses could be evoked by thrombin versus synthetic peptide agonists.
48. McLaughlin, J.N., Shen, L., Holinstat, M., Brooks, J.D., DiBenedetto, E., and Hamm, H.E. Functional selectivity of G Protein signaling by agonist peptides and phrombin for the protease-activated receptor-1. J. Biol. Chem. 280, 25048-25059 (2005). The results in this article demonstrate for the first time differences in the preference of PAR1 coupling to distinct G-protein subtypes induced by proteolytic activation by thrombin versus synthetic peptide ligands. (Pubitemid 40934596)
49. Komarova, Y.A., Mehta, D., and Malik, A.B. Dual regulation of endothe- lial junctional permeability. Sci STKE 2007, p. re8 (2007). An excellent comprehensive review on thrombin regulation of endothelial barrier permeability.
50. Feistritzer, C., Schuepbach, R.A., Mosnier, L.O., Bush, L.A., Di Cera, E., Griffin, J.H., and Riewald, M. Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells. J. Biol. Chem. 281, 20077-20084 (2006).
51. Bernard, G.R., Vincent, J.L., Laterre, P.F. et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344, 699-709 (2001).
52. Ludeman, M.J., Kataoka, H., Srinivasas, Y., Esmon, N.L., Esmon, C.T., and Coughlin, S.R. PAR1 cleavage and signaling in response to activated protein C and thrombin. J. Biol.Chem. 280, 13122-13128 (2005).
53. Bae, J.S., Yang, L., and Rezaie, A.R. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc. Natl. Acad. Sci. USA 104, 2867-2872 (2007). The results in this article demonstrate for the first time that APC and its co-factor EPCR and PAR1 are localized to lipid rafts in endothelial cells. (Pubitemid 46327971)
54. Bae, J.-S., Yang, L., Manithody, C., and Rezaie, A.R. The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor-1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. Blood 110, 3909-3916 (2007). (Pubitemid 350248446)
55. Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J.E., Hansen, S.H., Nishimoto, I., and Lisanti, M.P. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem. 270, 15693-15701 (1995).
56. Razani, B., Engelman, J.A., Wang, X.B. et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276, 38121-38138 (2001). (Pubitemid 37384066)
57. Bae, J.S., Yang, L., and Rezaie, A.R. Lipid raft localization regulates the cleavage specificity of protease activated receptor-1 in endothelial cells. J. Thomb. Haemost. 6, 954-961 (2008).
58. Carlie-Klusacek, M.E. and Rizzo, V. Endothelial cytoskeletal reorganization in response to PAR1 stimulation is mediated by membrane rafts but not caveolae. Am. J. Physiol. Heart Circ. Physiol. 293, H366-H375 (2007). The results in the paper show for the first time that thrombin induced changes in the cytoskeleton are regulated by lipid raft but not caveolae, localization.
59. Awasthi, V., Mandal, S.K., Papanna, V., Rao, L.V.M., and Pendurthi, U.R. Modulation of tissue factor-factor Vila signaling by lipid rafts and caveo- lae. Arterioscler. Thromb. Vasc. Biol. 27, 1447-1455 (2008). The results in this article are the first to demonstrate that caveolae are required for TF-VIIa mediated but not for peptide agonist-mediated activation of PAR2.
60. Dorfleutner, A. and Ruf, W. Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation. Blood 102, 3998-4005 (2003).
61. Valdez-Taubas, J., and Pelham, H. Swf1-dependent palmitoylation of the SNARE Tlg1 prevents its ubiquitination and degradation. EMBO J. 24, 2524-2532 (2005). (Pubitemid 41076309)
62. Abrami, L., Leppla, S.H., and van der Groot, F.G. Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J. Cell Biol. 172, 309-320 (2006).
63. Wolfe, B.L., Marchese, A., and Trejo, J. Ubiquitination differentially regulates clathrin-dependent internalization of protease-activated receptor-1. J. Cell Biol. 177, 905-916 (2007).
64. Jacob, C., Cottrell, G.S., Gehringer, D., Schmidlin, F., Grady, E.F., and Bunnett, N.W. c-Cbl mediates ubiquitination, degradation, and down- regulation of human protease-activated receptor 2. J. Biol. Chem. 280, 16076-16087 (2005).
65. Simmons, M.A. Let's go rafting: Ligand functional selectivity may depend on membrane structure. Mol. Interv. 8, 281-283 (2008). This is an excellent short viewpoint on the function of membrane microdo- mains in GPCR functional selectivity.
66. Schmid, C.L., Raehal, K.M., and Bohn, L.M. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo. Proc. Natl. Acad. Sci. USA 105, 1079-1084 (2008). The results in this article demonstrate for the first time a role for p-arrestins in maintaining distinct signaling complexes important for conferring functional selectivity to the serotonin 2A receptor.
67. Bhatnagar, A., Sheffler, D.J., Kroeze, W.K., Compton-Toth, B.A., and Roth, B.L. Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Gaq-coupled protein receptors. J. Biol. Chem. 279, 34614-34623 (2004). (Pubitemid 39318091)
68. Marchese, A., Paing, M.M., Temple, B.R.S., and Trejo, J. G Protein- coupled receptor sorting to endosomes and lysosomes. Annu. Rev. Pharmcol. Toxicol. 48, 601-629 (2008).
69. Kelly, E., Bailey, C.P., and Henderson, G. Agonist-selective mechanisms of GPCR desensitization. Br. J. Phamacol. 153, S379-S388 (2008). This is an excellent comprehensive review on agonist-selective mechanisms of GPCR signaling and regulation.
70. Kohout, T.A., Nicholas, S.L., Perry, S.J., Reinhart, G., Junger, S., and Struthers, R.S. Differential desensitisation, receptor phosphorylation, | -arrestin recruitment, and ERK1/2 activation by two endogenous ligands for the CC chemokine receptor 7. J. Biol. Chem. 279, 23214-23222 (2004). The results in this paper are one of the first to demonstrate functional selectivity with different endogenous ligands for the CCR7 receptor. (Pubitemid 38685628)
71. Chen, C.H., Paing, M.M., and Trejo, J. Termination of protease-activated receptor-1 signaling by p-arrestins is independent of receptor phosphorylation. J. Biol.Chem. 279, 10020-10031 (2004).
72. Paing, M.M., Stutts, A.B., Kohout, T.A., Lefkowitz, R.J., and Trejo, J. |-arrestins regulate protease-activated receptor-1 desensitization but not internalization or down-regulation. J. Biol. Chem. 277, 1292-1300 (2002).
73. Trejo, J., Hammes, S.R., and Coughlin, S.R. Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting. Proc. Natl. Acad. Sci. USA 95, 13698-13702 (1998). (Pubitemid 28523035)